MEIP
Price
$6.74
Change
+$0.14 (+2.12%)
Updated
Jul 25 closing price
Capitalization
44.91M
NRIX
Price
$11.52
Change
-$0.01 (-0.09%)
Updated
Jul 25 closing price
Capitalization
880.7M
74 days until earnings call
Interact to see
Advertisement

MEIP vs NRIX

Header iconMEIP vs NRIX Comparison
Open Charts MEIP vs NRIXBanner chart's image
MEI Pharma
Price$6.74
Change+$0.14 (+2.12%)
Volume$590.33K
Capitalization44.91M
Nurix Therapeutics
Price$11.52
Change-$0.01 (-0.09%)
Volume$476.86K
Capitalization880.7M
MEIP vs NRIX Comparison Chart in %
Loading...
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MEIP vs. NRIX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEIP is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (MEIP: $6.74 vs. NRIX: $11.52)
Brand notoriety: MEIP and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MEIP: 46% vs. NRIX: 54%
Market capitalization -- MEIP: $44.91M vs. NRIX: $880.7M
MEIP [@Biotechnology] is valued at $44.91M. NRIX’s [@Biotechnology] market capitalization is $880.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEIP’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • MEIP’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, MEIP is a better buy in the long-term than NRIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEIP’s TA Score shows that 4 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • MEIP’s TA Score: 4 bullish, 4 bearish.
  • NRIX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both MEIP and NRIX are a good buy in the short-term.

Price Growth

MEIP (@Biotechnology) experienced а +13.85% price change this week, while NRIX (@Biotechnology) price change was +2.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

NRIX is expected to report earnings on Oct 09, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($881M) has a higher market cap than MEIP($44.9M). MEIP YTD gains are higher at: 173.984 vs. NRIX (-38.853). MEIP has higher annual earnings (EBITDA): -22.17M vs. NRIX (-212.78M). NRIX has more cash in the bank: 486M vs. MEIP (20.5M). MEIP has less debt than NRIX: MEIP (11.7M) vs NRIX (51.9M). NRIX has higher revenues than MEIP: NRIX (88.4M) vs MEIP (0).
MEIPNRIXMEIP / NRIX
Capitalization44.9M881M5%
EBITDA-22.17M-212.78M10%
Gain YTD173.984-38.853-448%
P/E Ratio1.09N/A-
Revenue088.4M-
Total Cash20.5M486M4%
Total Debt11.7M51.9M23%
FUNDAMENTALS RATINGS
MEIP: Fundamental Ratings
MEIP
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
42
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MEIPNRIX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
89%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 25 days ago
82%
Declines
ODDS (%)
Bearish Trend 20 days ago
82%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 4 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DCZRX29.990.20
+0.67%
Macquarie Small Cap Core R6
MMSIX12.250.08
+0.66%
Praxis Small Cap Index I
VLCGX17.850.11
+0.62%
VALIC Company I Large Capital Growth
FALGX55.420.20
+0.36%
Fidelity Advisor Large Cap M
AMRGX7.090.01
+0.14%
American Growth One D

MEIP and

Correlation & Price change

A.I.dvisor tells us that MEIP and SYBX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEIP and SYBX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEIP
1D Price
Change %
MEIP100%
+2.12%
SYBX - MEIP
31%
Poorly correlated
-4.79%
TELO - MEIP
31%
Poorly correlated
-4.37%
INMB - MEIP
26%
Poorly correlated
-2.34%
NRIX - MEIP
26%
Poorly correlated
-0.09%
DNLI - MEIP
26%
Poorly correlated
-4.47%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-0.09%
KYMR - NRIX
68%
Closely correlated
-0.13%
DNLI - NRIX
62%
Loosely correlated
-4.47%
IDYA - NRIX
60%
Loosely correlated
-1.33%
RNA - NRIX
56%
Loosely correlated
+9.21%
OCUL - NRIX
55%
Loosely correlated
+2.43%
More